Natural Capsules Subsidiary Equity Dilution by 2.18%

Natural Capsules Ltd's Board of Directors has approved a resolution to not subscribe to the Rights Issue offered by its subsidiary, Natural Biogenex Private Limited. This decision, made via circulation on July 28, 2026, will result in a 2.18% dilution of Natural Capsules' equity stake in the subsidiary. The subsidiary's financials for the last fiscal year show a turnover of ₹13.43 Crore, a net worth of ₹81.24 Crore, and a loss of ₹43.30 Crore. The non-participation is attributed to strategic fund allocation for other business matters. Despite the dilution, Natural Biogenex Private Limited will remain a subsidiary of Natural Capsules Ltd.